SYRE

SYRE EBITDA Margin

-205.05%TTM

Period ending:

SYRE FY EBITDA Margin%
SYRE FY EBITDA Margin1731.20%-16157.83%
2014-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

SYRE ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.

Spyre Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
0%
0%
-14,426.6366%
-3,520.2662%
-341.982%
0%
0%
-1,161.7798%
-526.9356%
-470.484%
-184.4864%
0%

Compare ebitda margin

All SYRE financial metrics · SYRE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.